<DOC>
	<DOCNO>NCT02152358</DOCNO>
	<brief_summary>The aim study show preemptive treatment ganciclovir ( positive CMV viremia ) aciclovir ( positive HSV oro-pharyngeal PCR ) able increase number ventilator-free day Day 60 .</brief_summary>
	<brief_title>PTH - Preemptive Treatment Herpesviridae</brief_title>
	<detailed_description />
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Pneumonia , Viral</mesh_term>
	<mesh_term>Ganciclovir</mesh_term>
	<mesh_term>Acyclovir</mesh_term>
	<mesh_term>Ganciclovir triphosphate</mesh_term>
	<criteria>mechanical ventilation &gt; 96 hr expect duration mechanical ventilation least 2 day positive blood CMV PCR ( 500 IU/ml ) OR positive oropharyngeal HSV PCR age &gt; 18 year informed consent negative pregnancy test &lt; 18 year Receiving ganciclovir aciclovir another antiviral agent active HSV/CMV Had receive antiviral agent active HSV/CMV previous month Hypersensitivity aciclovir/ganciclovir Pregnancy Breast feed Bone marrow failure Solid organ recipient Bone marrow recipient HIV positive patient Receiving immunosuppressive agent SAPS II &gt; 75 Withdrawing/withholding Neutropenia ( &lt; 500 mm3 ) Thrombocytopenia ( &lt; 25 G/L ) ICU readmission</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>Cytomegalovirus</keyword>
	<keyword>Herpes simplex virus</keyword>
	<keyword>ICU</keyword>
	<keyword>mechanical ventilation</keyword>
	<keyword>mortality</keyword>
	<keyword>ventilator-free day</keyword>
	<keyword>PCR</keyword>
</DOC>